Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/322098

Lähdeviite

CardShock Investigators , Hongisto , M , Kataja , A , Tarvasmäki , T , Holopainen , A , Javanainen , T , Jurkko , R , Jäntti , T , Kimmoun , A , Levy , B , Mebazaa , A , Pulkki , K , Sionis , A , Tolppanen , H , Wollert , K C , Harjola , V-P & Lassus , J 2019 , ' Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock ' , Journal of Cardiac Failure , vol. 25 , no. 11 , pp. 894-901 . https://doi.org/10.1016/j.cardfail.2019.07.003

Julkaisun nimi: Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock
Tekijä: CardShock Investigators; Hongisto, Mari; Kataja, Anu; Tarvasmäki, Tuukka; Holopainen, Anu; Javanainen, Tuija; Jurkko, Raija; Jäntti, Toni; Kimmoun, Antoine; Levy, Bruno; Mebazaa, Alexandre; Pulkki, Kari; Sionis, Alessandro; Tolppanen, Heli; Wollert, Kai C.; Harjola, Veli-Pekka; Lassus, Johan
Tekijän organisaatio: HUS Emergency Medicine and Services
Department of Diagnostics and Therapeutics
University of Helsinki
Clinicum
HUS Heart and Lung Center
Kardiologian yksikkö
Department of Medicine
Päiväys: 2019-11
Kieli: eng
Sivumäärä: 8
Kuuluu julkaisusarjaan: Journal of Cardiac Failure
ISSN: 1071-9164
DOI-tunniste: https://doi.org/10.1016/j.cardfail.2019.07.003
URI: http://hdl.handle.net/10138/322098
Tiivistelmä: Background: The aim of this study was to assess the levels, kinetics, and prognostic value of growth differentiation factor 15 (GDF-15) in cardiogenic shock (CS). Methods and Results: Levels of GDF-15 were determined in serial plasma samples (0-120 h) from 177 CS patients in the CardShock study. Kinetics of GDF-15, its association with 90-day mortality, and incremental value for risk stratification were assessed. The median GDF-15(0h) level was 9647 ng/L (IQR 4500-19,270 ng/L) and levels above median were significantly associated with acidosis, hyperlactatemia, renal dysfunction, and higher 90-day mortality (56% vs 28%, P7000 ng/L was identified as a strong predictor of death (OR 5.0; 95% CI 1.9-3.8, P=.002). Adding GDF-15(12h) >7000 ng/L to the CardShock risk score improved discrimination and risk stratification for 90-day mortality. Conclusions: GDF-15 levels are highly elevated in CS and associated with markers of systemic hypoperfusion and end-organ dysfunction. GDF-15 helps to discriminate survivors from non-survivors very early in CS.
Avainsanat: Cardiogenic shock
growth differentiation factor 15 (GDF-15)
prognosis
biomarkers
CHRONIC HEART-FAILURE
BIOMARKERS
ASSOCIATION
INSIGHTS
UTILITY
SCORE
AGE
3126 Surgery, anesthesiology, intensive care, radiology
3121 General medicine, internal medicine and other clinical medicine
Vertaisarvioitu: Kyllä
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
1_s2.0_S1071916419302076_main.pdf 601.7KB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot